News und Analysen
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU delivers resilient top-line growth and confirms full-year guidance in Q1 2022/2023
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU delivers resilient top-line growth and confirms full-year guidance in Q1 2022/2023
DGAP-News: Instone Real Estate Group SE: AGM approves dividend payout of EUR 0.62 per share; CFO Foruhar Madjlessi's contract extended
DGAP-News: Instone Real Estate Group SE: AGM approves dividend payout of EUR 0.62 per share; CFO Foruhar Madjlessi's contract extended
DGAP-News: ABOUT YOU Holding SE: The ABOUT YOU Awards 2022 honour Europe's leading content creators and reach 652 million social media contacts
DGAP-News: ABOUT YOU Holding SE: The ABOUT YOU Awards 2022 honour Europe's leading content creators and reach 652 million social media contacts
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-News: Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Stefan Hoops appointed new CEO of DWS as Asoka Wöhrmann resigns
DGAP-Adhoc: DWS Group GmbH & Co. KGaA: Stefan Hoops appointed new CEO of DWS as Asoka Wöhrmann resigns
DGAP-News: ABOUT YOU Holding SE: ESG Report 2021/2022: ABOUT YOU publishes sustainability report and expands its sustainability strategy
DGAP-News: ABOUT YOU Holding SE: ESG Report 2021/2022: ABOUT YOU publishes sustainability report and expands its sustainability strategy
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU releases strong full-year results and expects significant growth in FY 2022/2023
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU releases strong full-year results and expects significant growth in FY 2022/2023
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: Dermapharm Holding SE: excellent start into financial year 2022
DGAP-News: SYNLAB reports a strong start to the fiscal year 2022
DGAP-News: SYNLAB reports a strong start to the fiscal year 2022
DGAP-News: Instone with solid start to the year – Suspension of guidance due to significantly increased uncertainty and limited visibility
DGAP-News: Instone with solid start to the year – Suspension of guidance due to significantly increased uncertainty and limited visibility
DGAP-Adhoc: Instone Real Estate Group SE: Financial Forecast for 2022 suspended due to significantly increased short-term uncertainty and limited visibility; Business development as expected in Q1 – 2022
DGAP-Adhoc: Instone Real Estate Group SE: Financial Forecast for 2022 suspended due to significantly increased short-term uncertainty and limited visibility; Business development as expected in Q1 – 2022
DGAP-News: SYNLAB AG: SYNLAB Medical Congress: making healthcare future-proof with advanced diagnostics
DGAP-News: SYNLAB AG: SYNLAB Medical Congress: making healthcare future-proof with advanced diagnostics
DGAP-News: Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation)
DGAP-News: Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation)
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU Awards goes Europe: The AYAs 2022 celebrate their international premiere and take place in the fashion metropolis Milan for the first time
DGAP-News: ABOUT YOU Holding SE: ABOUT YOU Awards goes Europe: The AYAs 2022 celebrate their international premiere and take place in the fashion metropolis Milan for the first time
DGAP-News: ESG Report 2021: SYNLAB defines high-impact areas to drive its ambitious environmental, social and governance agenda
DGAP-News: ESG Report 2021: SYNLAB defines high-impact areas to drive its ambitious environmental, social and governance agenda
DGAP-News: Q1 2022: DWS With Resilience and Strong Financial Results
DGAP-News: Q1 2022: DWS With Resilience and Strong Financial Results
DGAP-HV: SYNLAB AG: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am 16.05.2022 in München mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: SYNLAB AG: Korrektur: Bekanntmachung der Einberufung zur Hauptversammlung am 16.05.2022 in München mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: SYNLAB AG: Bekanntmachung der Einberufung zur Hauptversammlung am 16.05.2022 in München mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-HV: SYNLAB AG: Bekanntmachung der Einberufung zur Hauptversammlung am 16.05.2022 in München mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
DGAP-News: ABOUT YOU Holding SE: HYPEWEAR - Digital Fashion by ABOUT YOU: Das Fashion-Tech-Unternehmen gründet eine Plattform für digitale Fashion
DGAP-News: ABOUT YOU Holding SE: HYPEWEAR - Digital Fashion by ABOUT YOU: Das Fashion-Tech-Unternehmen gründet eine Plattform für digitale Fashion
DGAP-News: ABOUT YOU Holding SE: HYPEWEAR - Digital Fashion by ABOUT YOU: The fashion tech company launches a digital fashion platform
DGAP-News: ABOUT YOU Holding SE: HYPEWEAR - Digital Fashion by ABOUT YOU: The fashion tech company launches a digital fashion platform
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE records best ever year in 2021 - continuous growth in financial year 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: Dermapharm Holding SE: 2021 erfolgreichstes Jahr der Firmengeschichte - kontinuierliches Wachstum im Geschäftsjahr 2022
DGAP-News: SYNLAB AG: Kooperation zwischen SYNLAB und OncoDNA bringt umfassenden Biomarker-Test für Therapiewahl zur Krebsbehandlung nach Deutschland
DGAP-News: SYNLAB AG: Kooperation zwischen SYNLAB und OncoDNA bringt umfassenden Biomarker-Test für Therapiewahl zur Krebsbehandlung nach Deutschland
DGAP-News: SYNLAB AG: SYNLAB partners with OncoDNA to provide comprehensive biomarker testing for cancer therapy selection in Germany
DGAP-News: SYNLAB AG: SYNLAB partners with OncoDNA to provide comprehensive biomarker testing for cancer therapy selection in Germany
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022
DGAP-News: Dermapharm Holding SE: Kontinuierliches Wachstum von Konzernumsatz und bereinigtem Konzern-EBITDA in 2022